Gilead False Claims Case Dismissed On Motion By United States

Mealey's (November 21, 2019, 8:54 AM EST) -- SAN FRANCISCO — A California federal judge on Nov. 5 granted a motion by the United States to dismiss a whistleblower lawsuit alleging that drug maker Gilead Sciences Inc. caused false claims to be submitted to Medicare and Medicaid by using drug ingredients supplied by an unregistered Chinese supplier (United States, ex rel. Jeff Campie, et al. v. Gilead Sciences, Inc., et al., No. 11-941, N.D. Calif., 2019 U.S. Dist. LEXIS 193147)....

Attached Documents

Related Sections